Kawade A, Dayma G, Apte A, Telang N, et al. Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (Synflorix(TM) and Prevenar13(TM))) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-lab Vaccine 2023 Apr 10:S0264-410X(23)00388-2. doi: 10.1016/j.vaccine.2023.
PMID: 37045679